Journal of Asthma and Allergy
Volume 15, 2022 - Issue
Open access
168
Views
5
CrossRef citations to date
0
Altmetric
Short Report
Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
Claire Hopkins1 Department of Otorhinolaryngology – Head and Neck Surgery, Guy’s and St Thomas’ NHS Foundation Trust, London, UKCorrespondence[email protected]
https://orcid.org/0000-0003-3993-1569View further author information
, https://orcid.org/0000-0003-3993-1569View further author information
Kathleen M Buchheit2 Division of Allergy and Clinical Immunology, Brigham and Women’s Hospital, Boston, MA, USAhttps://orcid.org/0000-0001-5977-851XView further author information
, Enrico Heffler3 Personalized Medicine, Asthma & Allergy – Humanitas Clinical and Research Center IRCCS, Milan, Italy;4 Department of Biomedical Sciences, Humanitas University, Milan, Italyhttps://orcid.org/0000-0002-0492-5663View further author information
, Noam A Cohen5 Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USAhttps://orcid.org/0000-0003-2600-6710View further author information
, Heidi Olze6 Department of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Berlin, Germanyhttps://orcid.org/0000-0001-9987-6392View further author information
, Asif H Khan7 Global Medical Affairs, Sanofi, Chilly-Mazarin, Francehttps://orcid.org/0000-0001-9158-0116View further author information
, Jérôme Msihid8 Health Economics and Value Assessment, Sanofi, Chilly-Mazarin, Francehttps://orcid.org/0000-0003-4733-5855View further author information
, Shahid Siddiqui9 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
, Scott Nash9 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
, Juby A Jacob-Nara10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAhttps://orcid.org/0000-0002-5372-8762View further author information
, Paul J Rowe10 Global Medical Affairs, Sanofi, Bridgewater, NJ, USAView further author information
& Yamo Deniz9 Medical Affairs, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USAView further author information
show all
Pages 767-773
|
Published online: 07 Jun 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.